2ccu: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2ccu.gif|left|200px]]<br /> | [[Image:2ccu.gif|left|200px]]<br /><applet load="2ccu" size="450" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2ccu" size="450" color="white" frame="true" align="right" spinBox="true" | |||
caption="2ccu, resolution 2.70Å" /> | caption="2ccu, resolution 2.70Å" /> | ||
'''HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4-METHANESULPHONYL-BENZYL)-PIERAZIN-1-YL)-1H-PYRAZOL-3-YL)-BENZENE-1,3-DIOL'''<br /> | '''HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4-METHANESULPHONYL-BENZYL)-PIERAZIN-1-YL)-1H-PYRAZOL-3-YL)-BENZENE-1,3-DIOL'''<br /> | ||
| Line 8: | Line 7: | ||
==About this Structure== | ==About this Structure== | ||
2CCU is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 2D9 as [http://en.wikipedia.org/wiki/ligand ligand]. | 2CCU is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 2D9 as [http://en.wikipedia.org/wiki/ligand ligand]. Known structural/functional Site: <scene name='pdbsite=AC1:2d9 Binding Site For Chain A'>AC1</scene>. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2CCU OCA]. | ||
==Reference== | ==Reference== | ||
| Line 38: | Line 37: | ||
[[Category: pyrazole]] | [[Category: pyrazole]] | ||
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Dec 18 19:17:56 2007'' | ||
Revision as of 20:08, 18 December 2007
|
HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4-METHANESULPHONYL-BENZYL)-PIERAZIN-1-YL)-1H-PYRAZOL-3-YL)-BENZENE-1,3-DIOL
OverviewOverview
Novel piperazinyl, morpholino and piperidyl derivatives of the, pyrazole-based Hsp90 inhibitor CCT018159 are described. Structure-activity, relationships have been elucidated by X-ray co-crystal analysis of the new, compounds bound to the N-terminal domain of human Hsp90. Key features of, the binding mode are essentially identical to the recently reported potent, analogue VER-49009. The most potent of the new compounds has a, methylsulfonylbenzyl substituent appended to the piperazine nitrogen, possesses an IC50 of less than 600 nM binding against the enzyme and, demonstrates low micromolar inhibition of tumour cell proliferation.
About this StructureAbout this Structure
2CCU is a Single protein structure of sequence from Homo sapiens with 2D9 as ligand. Known structural/functional Site: . Full crystallographic information is available from OCA.
ReferenceReference
4-Amino derivatives of the Hsp90 inhibitor CCT018159., Barril X, Beswick MC, Collier A, Drysdale MJ, Dymock BW, Fink A, Grant K, Howes R, Jordan AM, Massey A, Surgenor A, Wayne J, Workman P, Wright L, Bioorg Med Chem Lett. 2006 May 1;16(9):2543-8. Epub 2006 Feb 9. PMID:16480864
Page seeded by OCA on Tue Dec 18 19:17:56 2007